![Robert Connelly](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 537 337 $ in data 31/05/2026
Robert T.
Connelly was the founder of WikiCell Designs, Inc. since 2007, serving as Chief Executive Officer from 2007 to 2013.
Current jobs include President, CEO, Director & CAO at Elicio Therapeutics, Inc. since 2025 and Director at Rainier Wine, Inc. Former jobs include Chief Executive Officer at Pulmatrix Operating Co., Inc. from 2008 to 2012, Chief Executive Officer at Domantis Ltd. from 2001 to 2007, Chief Executive Officer at Veritas Pharmaceuticals, Inc., President, Chief Executive Officer & Director at Axcella Health, Inc. from 2015 to 2018, Chief Executive Officer & Director at Elicio Therapeutics, Inc. (United States) from 2018 to 2023, Chairman at AeroDesigns, Inc., Director at Anchiano Therapeutics Ltd. from 2018 to 2019, Director at Kaleido Biosciences, Inc. from 2015 to 2018, Principal at Abbott Laboratories, Senior Vice President-Sales & Marketing at BioVeris Corp., and Venture Partner at Flagship Pioneering, Inc. from 2013 to 2018.
Education includes an undergraduate degree from the University of Florida.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 09/04/2026 | 46.970 ( 0,25% ) | 537 337 $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| ELICIO THERAPEUTICS, INC. | Amministratore Delegato | 01/10/2018 |
Rainier Wine, Inc. | Direttore/Membro del Consiglio | - |
| Società | Posizione | Fine |
|---|---|---|
Elicio Therapeutics, Inc. (United States)
 Elicio Therapeutics, Inc. (United States) BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops novel immunotherapies for treatment of cancer and other diseases | Amministratore Delegato | 01/06/2023 |
| ANCHIANO THERAPEUTICS LTD | Direttore/Membro del Consiglio | 31/12/2019 |
Flagship Pioneering, Inc.
 Flagship Pioneering, Inc. Investment ManagersFinance Flagship Pioneering invests in companies located across the globe. The firm targets companies operating in the fields of therapeutics, life science tools & diagnostics, bioenergy, and cleantech sectors. It provides financing for seed, early and later-stage capital requirements. The firm makes co-investments and also acts as a lead investor. | Corporate Officer/Principal | 01/10/2018 |
| AXCA HEALPAR | Amministratore Delegato | 31/05/2018 |
| KALEIDO BIOSCIENCES, INC. | Direttore/Membro del Consiglio | 01/01/2018 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 17 |
|---|---|
Abbott Laboratories
 Abbott Laboratories Medical SpecialtiesHealth Technology Develops and manufactures medical devices, diagnostic systems, pharmaceuticals & nutritional products | Health Technology |
BioVeris Corp.
 BioVeris Corp. BiotechnologyHealth Technology Develops and manufactures diagnostic products | Health Technology |
Pulmatrix Operating Co., Inc.
 Pulmatrix Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for respiratory infectious diseases | Health Technology |
Domantis Ltd.
 Domantis Ltd. Pharmaceuticals: MajorHealth Technology Develops domain antibody therapeutics for treating highly unmet diseases | Health Technology |
Anchiano Therapeutics Ltd.
 Anchiano Therapeutics Ltd. BiotechnologyHealth Technology Provides biopharmaceutical services | Health Technology |
Elicio Therapeutics, Inc. (United States)
Elicio Therapeutics, Inc. (United States) BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops novel immunotherapies for treatment of cancer and other diseases | Health Technology |
Flagship Pioneering, Inc.
Flagship Pioneering, Inc. Investment ManagersFinance Flagship Pioneering invests in companies located across the globe. The firm targets companies operating in the fields of therapeutics, life science tools & diagnostics, bioenergy, and cleantech sectors. It provides financing for seed, early and later-stage capital requirements. The firm makes co-investments and also acts as a lead investor. | Finance |
University of Florida
 University of Florida Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Veritas Pharmaceuticals, Inc.
 Veritas Pharmaceuticals, Inc. Medical/Nursing ServicesHealth Services Provides medical imaging services | Health Services |
AeroDesigns, Inc.
 AeroDesigns, Inc. Industrial ConglomeratesProducer Manufacturing Manufactures novel devices and formulations that deliver natural nutrition through the act of breathing | Producer Manufacturing |
WikiCell Designs, Inc.
 WikiCell Designs, Inc. Containers/PackagingProcess Industries Develops edible forms of food and beverage packaging services | Process Industries |
Rainier Wine, Inc. | |
Axcella Health, Inc.
 Axcella Health, Inc. BiotechnologyHealth Technology Provides first-in-class precision therapeutic solutions to diseases with a focus on restoring amino acid biology | Health Technology |
Pulmatrix, Inc.
 Pulmatrix, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals for pulmonary disease | Health Technology |
Kaleido Biosciences, Inc.
 Kaleido Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biotechnology company which develops therapeutic products to systematically shape the micro biome | Health Technology |
Kintail, Inc.
 Kintail, Inc. Information Technology ServicesTechnology Services Operates as BI tool for data engineering and analytics | Technology Services |
Elicio Therapeutics, Inc.
 Elicio Therapeutics, Inc. BiotechnologyHealth Technology Develops cancer immunotherapies | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
